Dextrallorphan

Dextrallorphan is a chemical compound that acts as a dissociative anesthetic and is a metabolite of dextromethorphan, a common cough suppressant. It is known for its role in the central nervous system as an NMDA receptor antagonist.
Chemical Properties[edit]
Dextrallorphan is a member of the morphinan class of compounds. It is structurally related to dextromethorphan and levorphanol, sharing the morphinan backbone but differing in stereochemistry and functional groups.
Pharmacology[edit]
Dextrallorphan functions primarily as an NMDA receptor antagonist, which contributes to its dissociative effects. By inhibiting the NMDA receptor, dextrallorphan can interfere with the normal excitatory neurotransmission in the brain, leading to altered perception and cognition.
Metabolism[edit]
Dextrallorphan is produced in the body as a metabolite of dextromethorphan. The conversion occurs primarily in the liver through the action of the cytochrome P450 enzyme system, particularly CYP2D6.
Clinical Significance[edit]
While dextrallorphan itself is not used therapeutically, its parent compound, dextromethorphan, is widely used in over-the-counter cough medicine. The effects of dextrallorphan are considered when evaluating the safety and efficacy of dextromethorphan, especially in individuals with variations in CYP2D6 activity.
Research[edit]
Dextrallorphan has been studied for its potential neuroprotective effects due to its NMDA receptor antagonism. Research is ongoing to explore its role in conditions such as neurodegenerative diseases and neuropathic pain.
Related Compounds[edit]
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian